Circulating Immune Complexes as Markers of Response to Chemotherapy in Malignant Teratomas and Gestational Trophoblastic Tumours

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1982.36
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

International Symposium on Gestational Trophoblastic Tumours

British Journal of Cancer
Cancer ResearchOncology
1980English

Chemotherapy of Disseminated Malignant Tumours

BMJ
1974English

Lack of Mutation in Tumour-Suppressor Gene P53 in Gestational Trophoblastic Tumours

British Journal of Cancer
Cancer ResearchOncology
1996English

First Line Chemotherapy in Low Risk Gestational Trophoblastic Neoplasia

2008English

Pulmonary Metastases Increase Chemotherapy Resistance and Recurrence of Gestational Trophoblastic Neoplasia

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2020English

Letter: Chemotherapy of Disseminated Malignant Tumours.

BMJ
1974English

Impact of Temozolomide on Immune Response During Malignant Glioma Chemotherapy

Clinical and Developmental Immunology
2012English

Efficacy and Risk Factors Associated to Resistance to Single-Agent Chemotherapy in Low-Risk Gestational Trophoblastic Neoplasia

Open Journal of Obstetrics and Gynecology
2016English

Circulating Immune Complexes in Lyme Arthritis

Journal of Clinical Investigation
Medicine
1979English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy